Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, prospective, randomized, intra-individual half-side comparison proof-of-concept study of Verrumal solution versus vehicle in actinic keratosis
2006-005034-20Phase 2Terminated
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluorouracil + salicylic acid in actinic keratosis (AK) (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Global investigator assessment of actinic keratosis response. Started Nov 2006; status: terminated.
02
Drugs
fluorouracil + salicylic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2006-005034-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005034-20.